retatrutide mechanism triple agonist glp-1 gip glucagon receptor What GLP‑3 Really Is: Retatrutide Triple‑Receptor Drug Targeting GLP-1, GIP & GCG

The Introduction of Generics On June 22, 2024, Teva launched an authorized generic for Victoza (liraglutide) at a 13.6% discount

Some patients benefit from a small daily maintenance fiber dose (and, in some cases, polyethylene glycol) to remain regular while on therapy., When is constipation a medical concern

Glucagon-like peptide-1 receptor agonists and gastrointestinal cancer risk in individuals with type 2 diabetes

NS, not significant

Our GLP 1 weight loss doctors trust them, so you can too

In trials, retatrutide produced higher weight loss than Wegovy at the highest dose of each: 28.7% at 68 weeks on retatrutide 12 mg, versus 20.7% at 72 weeks on the newer Wegovy 7.2 mg dose, and 14.9% at 68 weeks on the older Wegovy 2.4 mg dose